Longitude Capital Partners Ii, Llc - Net Worth and Insider Trading
Longitude Capital Partners Ii, Llc Net Worth
The estimated net worth of Longitude Capital Partners Ii, Llc is at least $331 Million dollars as of 2024-09-20. Longitude Capital Partners Ii, Llc is the 10% Owner of Aimmune Therapeutics Inc and owns about 7,513,134 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $259 Million. Longitude Capital Partners Ii, Llc is the 10% Owner of Spot Mobile International Ltd and owns about 3,557,952 shares of Spot Mobile International Ltd (RPID) stock worth over $71 Million. Longitude Capital Partners Ii, Llc is also the 10% Owner of Aptinyx Inc and owns about 3,190,079 shares of Aptinyx Inc (APTX) stock worth over $306,248. Besides these, Longitude Capital Partners Ii, Llc also holds Kala Bio Inc (KALA) , Tricida Inc (TCDAQ) . Details can be seen in Longitude Capital Partners Ii, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longitude Capital Partners Ii, Llc has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Longitude Capital Partners Ii, Llc
Longitude Capital Partners Ii, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longitude Capital Partners Ii, Llc owns 7 companies in total, including Vaxcyte Inc (PCVX) , Venus Concept Inc (VERO) , and Tricida Inc (TCDAQ) among others .
Insider Ownership Summary of Longitude Capital Partners Ii, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCVX | Vaxcyte Inc | 2020-06-11 | 10 percent owner |
| VERO | Venus Concept Inc | 2019-11-07 | 10 percent owner |
| TCDAQ | Tricida Inc | 2018-07-02 | 10 percent owner |
 | | 2018-06-25 | 10 percent owner |
| | 2017-07-25 | 10 percent owner |
| | 2016-11-29 | 10 percent owner |
| | 2021-07-19 | 10 percent owner |
Longitude Capital Partners Ii, Llc Latest Holdings Summary
Longitude Capital Partners Ii, Llc currently owns a total of 5 stocks. Among these stocks, Longitude Capital Partners Ii, Llc owns 7,513,134 shares of Aimmune Therapeutics Inc (AIMT) as of March 29, 2016, with a value of $259 Million and a weighting of 78.4%. Longitude Capital Partners Ii, Llc owns 3,557,952 shares of Spot Mobile International Ltd (RPID) as of July 19, 2021, with a value of $71 Million and a weighting of 21.43%. Longitude Capital Partners Ii, Llc also owns 3,190,079 shares of Aptinyx Inc (APTX) as of June 25, 2018, with a value of $306,248 and a weighting of 0.09%. The other 2 stocks Kala Bio Inc (KALA) , Tricida Inc (TCDAQ) have a combined weighting of 0.08% among all his current holdings.
Latest Holdings of Longitude Capital Partners Ii, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2016-03-29 | 7,513,134 | 34.49 | 259,127,992 |
| RPID | Spot Mobile International Ltd | 2021-07-19 | 3,557,952 | 19.91 | 70,838,824 |
| APTX | Aptinyx Inc | 2018-06-25 | 3,190,079 | 0.10 | 306,248 |
| KALA | Kala Bio Inc | 2017-07-25 | 45,419 | 5.76 | 261,613 |
| TCDAQ | Tricida Inc | 2018-07-02 | 5,907,889 | 0.00 | 59 |
Holding Weightings of Longitude Capital Partners Ii, Llc
Longitude Capital Partners Ii, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 78,504 shares on March 29, 2016, which cost Longitude Capital Partners Ii, Llc around $1 Million.
According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 1 transactions in Spot Mobile International Ltd (RPID) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spot Mobile International Ltd is the acquisition of 150,000 shares on July 19, 2021, which cost Longitude Capital Partners Ii, Llc around $3 Million.
According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 0 transactions in Aptinyx Inc (APTX) over the past 5 years. The most-recent trade in Aptinyx Inc is the acquisition of 150,000 shares on June 25, 2018, which cost Longitude Capital Partners Ii, Llc around $2 Million.
More details on Longitude Capital Partners Ii, Llc's insider transactions can be found in the Insider Trading History of Longitude Capital Partners Ii, Llc table.Insider Trading History of Longitude Capital Partners Ii, Llc
- 1
Longitude Capital Partners Ii, Llc Trading Performance
GuruFocus tracks the stock performance after each of Longitude Capital Partners Ii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longitude Capital Partners Ii, Llc is -3.59%. GuruFocus also compares Longitude Capital Partners Ii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Longitude Capital Partners Ii, Llc within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longitude Capital Partners Ii, Llc's insider trading performs compared to the benchmark.
Performance of Longitude Capital Partners Ii, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.06 | | | | | |
| Relative Return to S&P 500(%) | -1.39 | | | | | |
Longitude Capital Partners Ii, Llc Ownership Network
Longitude Capital Partners Ii, Llc Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Longitude Capital Partners Ii, Llc is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include CFO & CBO Andrew Guggenhime , Chief Operating Officer Jim Wassil , and See Remarks Section Elvia Cowan .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Longitude Capital Partners Ii, Llc made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 191,168 shares made by Grant Pickering , a net sale of 110,000 shares made by Andrew Guggenhime , and a net sale of 50,000 shares made by Jim Wassil .
In summary, during the past 3 months, insiders sold 123,867 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 123,867 shares. During the past 18 months, 452,965 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 452,965 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
Longitude Capital Partners Ii, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Longitude Capital Partners Ii, Llc. You might contact Longitude Capital Partners Ii, Llc via mailing address: 800 El Camino Real, Suite 220, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
